-
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com
Source: Buzz FX / 28 Dec 2024 01:41:14 America/Chicago
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat December 28, 2024 Share Link copied to clipboard. StockNews.com started coverage on shares of Revance Therapeutics ( NASDAQ:RVNC - Get
Read more...